17-35440852-C-A
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_144682.6(SLFN13):c.2437G>T(p.Val813Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000483 in 1,614,034 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V813I) has been classified as Uncertain significance.
Frequency
Consequence
NM_144682.6 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152178Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000398 AC: 1AN: 251418 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.0000513 AC: 75AN: 1461856Hom.: 0 Cov.: 30 AF XY: 0.0000413 AC XY: 30AN XY: 727224 show subpopulations
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152178Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74320 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.2437G>T (p.V813F) alteration is located in exon 6 (coding exon 4) of the SLFN13 gene. This alteration results from a G to T substitution at nucleotide position 2437, causing the valine (V) at amino acid position 813 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at